共 50 条
- [4] Direct oral anticoagulants (DOAC) for patients with atrial fibrillation during the COVID-19 pandemic [J]. MEDICINA CLINICA, 2022, 159 (09): : E61 - E61
- [5] Direct oral anticoagulants (DOAC) for patients with atrial fibrillation during the COVID-19 pandemic Reply [J]. MEDICINA CLINICA, 2022, 159 (09): : E62 - E62
- [6] Implementation of warfarin to direct oral anticoagulant conversion initiative in pharmacist-run anticoagulation clinics during COVID-19 pandemic [J]. JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY, 2021, 4 (09): : 1154 - 1160
- [7] The Comparative Effectiveness and Safety of Direct Oral Anticoagulant (DOAC) and Warfarin Initiation in Adults with Atrial Fibrillation (AF) by eGFR Category [J]. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2021, 32 (10): : 37 - 37
- [9] Direct oral anticoagulant plasma levels in hospitalized COVID-19 patients treated with dexamethasone [J]. Journal of Thrombosis and Thrombolysis, 2022, 53 : 346 - 351
- [10] Participant stress in the COVID-19 era and beyond [J]. NATURE REVIEWS NEUROSCIENCE, 2020, 21 (12) : 663 - 664